Literature DB >> 1704215

Peripheral blood leukocytes as a surrogate marker for cisplatin drug resistance: studies of adduct levels and the repair gene ERCC1.

R J Parker1, M C Poirier, F Bostick-Bruton, J Vionnet, V A Bohr, E Reed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1704215     DOI： 10.1007/978-1-4613-0637-5_20

Source DB:  PubMed          Journal:  Basic Life Sci        ISSN： 0090-5542


× No keyword cloud information.
  2 in total

1.  Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro.

Authors:  M Dabholkar; L Bradshaw; R J Parker; I Gill; F Bostick-Bruton; F M Muggia; E Reed
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

2.  Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.

Authors:  Sandra G Boccard; Sandie V Marand; Sandra Geraci; Laurie Pycroft; François R Berger; Laurent A Pelletier
Journal:  Oncotarget       Date:  2015-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.